Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2021

Apr 26, 2021

SELL
$2.01 - $5.05 $11,657 - $29,290
-5,800 Reduced 96.67%
200 $0
Q4 2020

Jan 21, 2021

BUY
$1.89 - $2.55 $11,340 - $15,299
6,000 New
6,000 $11,000

Others Institutions Holding OBSV

About ObsEva SA


  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.